BUSULFAN
Generic: BUSULFAN
Pharmascience Inc.Manufacturer
INTRAVENOUSRoute
BUSULFANActive Substance
2017-03-24Original Approval
BUSULFAN is FDA application ANDA207050, sponsored by PHARMASCIENCE INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
OFF LABEL USE
2,073 reports
2
PRODUCT USE IN UNAPPROVED INDICATION
1,711 reports
3
MUCOSAL INFLAMMATION
1,079 reports
4
DRUG INEFFECTIVE
1,071 reports
5
GRAFT VERSUS HOST DISEASE
904 reports
6
VENOOCCLUSIVE LIVER DISEASE
878 reports
7
CYTOMEGALOVIRUS INFECTION
869 reports
8
FEBRILE NEUTROPENIA
852 reports
9
ACUTE GRAFT VERSUS HOST DISEASE
824 reports
10
PYREXIA
818 reports